I used Humira too. For 1 infusion and failed it. Whilst Humira is a complex drug, the body can develop antibodies to fight against its reliability and effectiveness. Keep in mind the cost of Humira in the U.S alone isn't accessible to all due to its cost and the hoops patients jump through for 3 months to years just to qualify for it due to progression of condition requirements. It won't replace it but could potentially help patients who cant afford it or biologics haven't worked for. The potential for this kind of advancement for patients to also avoid opiates is very promising. I'm no expert by any means but competition for drugs like Humira with ranging side affects is a good thing.
- Forums
- ASX - By Stock
- CGB
- Ann: Breakthrough for GMP Quality Medicinal Cannabis
Ann: Breakthrough for GMP Quality Medicinal Cannabis, page-45
-
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online